Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-28

FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves the original application for rivastigmine tartrate (generic) manufactured by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine tartrate (rivastigmine tartrate)

Snippet

ORIG AP for RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)